PURINE AND 8-SUBSTITUTED PURINE ARABINOFURANOSYL AND RIBOFURANOSYL NUCLEOSIDE DERIVATIVES AS POTENTIAL INDUCERS OF THE DIFFERENTIATION OF THE FRIEND-ERYTHROLEUKEMIA
PURINE AND 8-SUBSTITUTED PURINE ARABINOFURANOSYL AND RIBOFURANOSYL NUCLEOSIDE DERIVATIVES AS POTENTIAL INDUCERS OF THE DIFFERENTIATION OF THE FRIEND-ERYTHROLEUKEMIA
复制标题
DOI:
10.1021/jm00148a018
复制
发表时间:
1985-01-01
影响因子:
7.3
通讯作者:
SARTORELLI, AC
中科院分区:
文献类型:
--
作者:
LIN, TS;CHENG, JC;SARTORELLI, AC
Several antimetabolites have been demonstrated to have the capacity to initiate differentiation in vitro of a variety of leukemic cell lines. To explore the structural requirements for this activity, a series of purine and 8-substituted purine arabinofuranosyl and ribofuranosyl nucleoside derivatives were synthesized and tested as inducers of the differentiation of Friend murine erythroleukemia cells. 9-(.beta.-D-Arabinofuranosyl)hypoxanthine and 6-(hydroxyamino)-9-(.beta.-D-arabinofuranosyl)purine were effective inducers if maturation, producing 82% and 74% benzidine-positive cells, a measure of the number of cells synthesizing hemoglobin. 6-Mercapto-9-(.beta.-D-ribofuranosyl)purine and 6-(methylmercapto)-9-(.beta.-D ribofuranosyl)purine and their corresponding .beta.-D-arabinofuranosyl derivatives were also effective initiators of maturation, causing approximately 50% of the cell population to assume a differentiated phenotype.